JURAČKA, Stanislav, Barbora HRNČÍŘOVÁ, Barbora BURÝŠKOVÁ, Daniel GEORGIEV a Pavel DVOŘÁK. Building the SynBio community in the Czech Republic from the bottom up: You get what you give. Biotechnology Notes. Elsevier B.V., 2022, roč. 3, December, s. 124-134. ISSN 2665-9069. Dostupné z: https://dx.doi.org/10.1016/j.biotno.2022.11.002.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Building the SynBio community in the Czech Republic from the bottom up: You get what you give
Autoři JURAČKA, Stanislav (203 Česká republika, domácí), Barbora HRNČÍŘOVÁ (203 Česká republika, domácí), Barbora BURÝŠKOVÁ (203 Česká republika, domácí), Daniel GEORGIEV a Pavel DVOŘÁK (203 Česká republika, garant, domácí).
Vydání Biotechnology Notes, Elsevier B.V. 2022, 2665-9069.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 20801 Environmental biotechnology
Stát vydavatele Nizozemské království
Utajení není předmětem státního či obchodního tajemství
WWW URL
Kód RIV RIV/00216224:14310/22:00127501
Organizační jednotka Přírodovědecká fakulta
Doi http://dx.doi.org/10.1016/j.biotno.2022.11.002
Klíčová slova anglicky Synthetic biology; Czech Republic; EU13 countries; Community; iGEM; Research landscape; Biotechnology and bioengineering; Public perception
Štítky rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Marie Šípková, DiS., učo 437722. Změněno: 19. 12. 2022 08:41.
Anotace
Given its highly innovative character and potential socioeconomic impact, Synthetic Biology is often ranked among prominent research areas and national research priorities in developed countries. The global evolution of this field is proceeding by leaps and bounds but its development at the level of individual states varies widely. Despite their current satisfactory economic status, the majority of 13, mostly post-communist, countries that entered the European Union family in and after 2004 (EU13) have long overlooked the blossoming of Synthetic Biology. Their prioritized lines of research have been directed elsewhere or “Synthetic Biology” did not become a widely accepted term to encompass their bioengineering and biotechnology domains. The Czech Republic is not an exception. The local SynBio mycelium already exists but is mainly built bottom-up through the activities of several academic labs, iGEM teams, and spin-off companies. In this article, we tell their individual stories and summarize the prerequisites that allowed their emergence in the Czech academic and business environment. In addition, we provide the reader with a brief overview of laboratories, research hubs, and companies that perform biotechnology and bioengineering-oriented research and that may be included in a notional “shadow SynBio community” but have not yet adopted Synthetic Biology as a unifying term for their ventures. We also map the current hindrances for a broader expansion of Synthetic Biology in the Czech Republic and suggest possible steps that should lead to the maturity of this fascinating research field in our country.
Návaznosti
GA22-10845S, projekt VaVNázev: Studium role polyhydroxyalkanoátů u bakterie Schlegelella thermodepolymerans – slibného bakteriálního kandidáta pro biotechnologie nové generace (Akronym: PHAST)
Investor: Grantová agentura ČR, Studium role polyhydroxyalkanoátů u bakterie Schlegelella thermodepolymerans – slibného bakteriálního kandidáta pro biotechnologie nové generace
MUNI/J/0003/2021, interní kód MUNázev: A new generation bacterial platform for lignocellulose biotechnology (Akronym: NEWGEN)
Investor: Masarykova univerzita, A new generation bacterial platform for lignocellulose biotechnology, MASH JUNIOR - MUNI Award In Science and Humanities JUNIOR
VytisknoutZobrazeno: 22. 8. 2024 21:50